NIDO is a medical device company developing SEPIA, an innovative device to improve epicardial ablation for ventricular tachycardia (VT), based on technology developed at Boston Children’s Hospital. SEPIA will enable real-time visualization of the epicardial surface and provide angle and force control to ablation catheters, resulting in improved ablation efficiency, decreased VT recurrence and fewer complications.

The company was co-founded by Dr. Pedro del Nido, Chairman of Cardiovascular Surgery and Professor at Harvard Medical School, and Dr. Nikolay Vasilyev, former Assistant Professor of Surgery at Harvard Medical School, currently Medical Director for the Surgicals Portfolio at Pfizer.

http://www.nidosurgical.com